Advertisement

Topics

Teva Pharmaceutical Industries (TEVA) Expected to Post Quarterly Sales of $4.72 Billion

23:14 EDT 13 May 2018 | Topix

Wall Street brokerages predict that Teva Pharmaceutical Industries will post sales of $4.72 billion for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Teva Pharmaceutical Industries' earnings, with the highest sales estimate coming in at $4.83 billion and the lowest estimate coming in at $4.61 billion.

Original Article: Teva Pharmaceutical Industries (TEVA) Expected to Post Quarterly Sales of $4.72 Billion

NEXT ARTICLE

More From BioPortfolio on "Teva Pharmaceutical Industries (TEVA) Expected to Post Quarterly Sales of $4.72 Billion"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...